본문 바로가기
KERD
논문KCI 등재

Glutamine as an Immunonutrient

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류의학일반

초록

Dietary supplementation with nutrients enhancing immune function is beneficial in patients with surgical and critical illness. Malnutrition and immune dysfunction are common features in hospitalized patients. Specific nutrients with immunological and pharmacological effects, when consumed in amounts above the daily requirement,are referred to as immune-enhancing nutrients or immunonutrients. Supplementation of immunonutrients is important especially for patients with immunodeficiency,virus or overwhelming infections accompanied by a state of malnutrition. Representative immunonutrients are arginine, omega-3 fatty acids, glutamine,nucleotides, beta-carotene, and/or branched-chain amino acids. Glutamine is the most abundant amino acid and performs multiple roles in human body. However,glutamine is depleted from muscle stores during severe metabolic stress including sepsis and major surgery. Therefore it is considered conditionally essential under these conditions. This review discusses the physiological role of glutamine, mode and dose for glutamine administration, as well as improvement of certain disease state after glutamine supplementation. Even though immunonutrition has not been widely assimilated by clinicians other than nutritionists, immunonutrients including glutamine may exert beneficial influence on diverse patient populations.

Abstract

Dietary supplementation with nutrients enhancing immune function is beneficial in patients with surgical and critical illness. Malnutrition and immune dysfunction are common features in hospitalized patients. Specific nutrients with immunological and pharmacological effects, when consumed in amounts above the daily requirement,are referred to as immune-enhancing nutrients or immunonutrients. Supplementation of immunonutrients is important especially for patients with immunodeficiency,virus or overwhelming infections accompanied by a state of malnutrition. Representative immunonutrients are arginine, omega-3 fatty acids, glutamine,nucleotides, beta-carotene, and/or branched-chain amino acids. Glutamine is the most abundant amino acid and performs multiple roles in human body. However,glutamine is depleted from muscle stores during severe metabolic stress including sepsis and major surgery. Therefore it is considered conditionally essential under these conditions. This review discusses the physiological role of glutamine, mode and dose for glutamine administration, as well as improvement of certain disease state after glutamine supplementation. Even though immunonutrition has not been widely assimilated by clinicians other than nutritionists, immunonutrients including glutamine may exert beneficial influence on diverse patient populations.

참고문헌 (58)

  1. Kudsk KA, "A randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complications", Ann Surg, 224, pp.531~540 (1996)
  2. Koletzko S, "Progress of enteral feeding practice over time: moving from energy supply to patient- and disease-adapted formulations", Nestle Nutr Workshop Ser Pediatr Program, 66, pp.41~54 (2010)
  3. Kudsk KA, "Enteral versus parenteral feeding. Effects on septic morbidity after blunt and penetrating abdominal trauma", Ann Surg, 215, pp.503~511 (1992)
  4. Alivizatos V, "Early postoperative glutamine-supplemented parenteral nutrition versus enteral immunonutrition in cancer patients undergoing major gastrointestinal surgery", J BUON, 10, pp.119~122 (2005)
  5. Słotwiński R, "Innate immunity signaling pathways: links between immunonutrition and responses to sepsis", Arch Immunol Ther Exp (Warsz), 59, pp.139~150 (2011)
  6. Kurmis R, "The use of immunonutrition in burn injury care: where are we", J Burn Care Res, 31, pp.677~691 (2010)
  7. Mizock BA, "Immunonutrition and critical illness: an update", Nutrition, 26, pp.701~707 (2010)
  8. Kudsk KA, "Immunonutrition in surgery and critical care", Annu Rev Nutr, 26, pp.463~479 (2006)
  9. Beisel WR, "History of nutritional immunology: introduction and overview", J Nutr, 122, pp.591~596 (1992)
  10. Grimble RF, "Immunonutrition", Curr Opin Gastroenterol, 21, pp.216~222 (2005)
  11. Souba WW, "Glutamine: a key substrate for the splanchnic bed", Annu Rev Nutr, 11, pp.285~308 (1991)
  12. Wilmore DW, "The gut: a central organ after surgical stress", Surgery, 104, pp.917~923 (1988)
  13. Windmueller HG, "Uptake and metabolism of plasma glutamine by the small intestine", J Biol Chem, 249, pp.5070~7079 (1974)
  14. Lacey JM, "Is glutamine a conditionally essential amino acid", Nutr Rev, 48, pp.297~309 (1990)
  15. Brasse-Lagnel CG, "Amino acid regulation of mammalian gene expression in the intestine", Biochimie, 92, pp.729~735 (2010)
  16. Gstraunthaler G, "Ammoniagenesis in LLC-PK1 cultures: role of transamination", Am J Physiol, 263, pp.C47~C54 (1992)
  17. Wischmeyer PE, "Glutamine: mode of action in critical illness", Crit Care Med, 35, pp.S541~S544 (2007)
  18. Rhoads JM, "L-glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases", Am J Physiol, 272, pp.G943~G953 (1997)
  19. Huang Y, "Immunonutrients and neonates", Eur J Pediatr, 162, pp.122~128 (2003)
  20. Wessner B, "Effect of single and combined supply of glutamine, glycine, N-acetylcysteine, and R,S-alpha-lipoic acid on glutathione content of myelomonocytic cells", Clin Nutr, 22, pp.515~522 (2003)
  21. Cetinbas F, "Role of glutamine administration on cellular immunity after total parenteral nutrition enriched with glutamine in patients with systemic inflammatory response syndrome", J Crit Care, 25(661), pp.1~6 (2010)
  22. dos Santos RG, "Glutamine supplementation decreases intestinal permeability and preserves gut mucosa integrity in an experimental mouse model", JPEN J Parenter Enteral Nutr, 34, pp.408~413 (2010)
  23. Andrews FJ, "Glutamine: essential for immune nutrition in the critically ill", Br J Nutr, 87(Suppl 1), pp.S3~S8 (2002)
  24. Xu J, "Immunonutrition in surgical patients", Curr Drug Targets, 10, pp.771~777 (2009)
  25. Klek S, "Immunonutrition in cancer patients", Nutrition, 27, pp.144~145 (2011)
  26. Ziegler TR, "Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study", Ann Intern Med, 116, pp.821~828 (1992)
  27. van Zaanen HC, "Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity", Cancer, 74, pp.2879~2884 (1994)
  28. Noé JE, "L-glutamine use in the treatment and prevention of mucositis and cachexia: a naturopathic perspective", Integr Cancer Ther, 8, pp.409~415 (2009)
  29. Izaola O, "Influence of an immuno-enhanced formula in postsurgical ambulatory patients with head and neck cancer", Nutr Hosp, 25, pp.793~796 (2010)
  30. Singleton KD, "Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression", Crit Care Med, 33, pp.1206~1213 (2005)
  31. O’Riordain MG, "Effect of glutamine on immune function in the surgical patient", Nutrition, 12, pp.S82~S84 (1996)
  32. Lu CY, "The inflammatory modulation effect of glutamine-enriched total parenteral nutrition in postoperative gastrointestinal cancer patients", Am Surg, 77, pp.59~64 (2011)
  33. Lecleire S, "Combined glutamine and arginine decrease proinflammatory cytokine production by biopsies from Crohn’s patients in association with changes in nuclear factor-kappaB and p38 mitogen-activated protein kinase pathways", J Nutr, 138, pp.2481~2486 (2008)
  34. Ziegler TR, "Parenteral glutamine increases serum heat shock protein 70 in critically ill patients", Intensive Care Med, 31, pp.1079~1086 (2005)
  35. Singleton KD, "Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression", Crit Care Med, 33, pp.1206~1213 (2005)
  36. van de Poll MC, "Intestinal and hepatic metabolism of glutamine and citrulline in humans", J Physiol, 581, pp.819~827 (2007)
  37. van de Poll MC, "Interorgan amino acid exchange in humans: consequences for arginine and citrulline metabolism", Am J Clin Nutr, 85, pp.167~172 (2007)
  38. Déchelotte P, "L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study", Crit Care Med, 34, pp.598~604 (2006)
  39. Cario E, "Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors", J Immunol, 164, pp.966~972 (2000)
  40. Kessel A, "Treatment with glutamine is associated with down-regulation of Toll-like receptor-4 and myeloid differentiation factor 88 expression and decrease in intestinal mucosal injury caused by lipopolysaccharide endotoxaemia in a rat", Clin Exp Immunol, 151, pp.341~347 (2008)
  41. Abreu MT, "Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide", J Immunol, 167, pp.1609~1616 (2001)
  42. Boelens PG, "Route of administration (enteral or parenteral) affects the contribution of L-glutamine to de novo L-arginine synthesis in mice: a stable-isotope study", Am J Physiol Endocrinol Metab, 291, pp.E683~E690 (2006)
  43. Haynes TE, "L-Glutamine or L-alanyl-L-glutamine prevents oxidant- or endotoxin-induced death of neonatal enterocytes", Amino Acids, 37, pp.131~142 (2009)
  44. glutamine into citrulline and arginine in humans, "JPEN J Parenter Enteral Nutr", 2007, 343~348
  45. Fuentes-Orozco C, "L-alanyl-L-glutamine-supplemented parenteral nutrition improves infecglutamine tious morbidity in secondary peritonitis", Clin Nutr, 23, pp.13~21 (2004)
  46. Loï C, "Increasing plasma glutamine in postoperative patients fed an arginine-rich immune-enhancing diet--a pharmacokinetic randomized controlled study", Crit Care Med, 37, pp.501~509 (2009)
  47. Sevastiadou S, "The impact of oral glutamine supplementation on the intestinal permeability and incidence of necrotizing enterocolitis", septicemia in premature neonates, 2011, ~
  48. Houdijk AP, "Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma", Lancet, 352, pp.772~776 (1998)
  49. Wernerman J, "Scandinavian glutamine trial: a pragmatic multi-centre randomised clinical trial of intensive care unit patients", Acta Anaesthesiol Scand, 55, pp.812~818 (2011)
  50. Cetinbas F, "Role of glutamine administration on cellular immunity after total parenteral nutrition enriched with glutamine in patients with systemic inflammatory response syndrome", J Crit Care, 25(661), pp.1~6 (2010)
  51. Oudemans-van Straaten HM, "Plasma glutamine depletion and patient outcome in acute ICU admissions", Intensive Care Med, 27, pp.84~90 (2001)
  52. Novak F, "Glutamine supplementation in serious illness: a systematic review of the evidence", Crit Care Med, 30, pp.2022~2029 (2002)
  53. Schloerb PR, "Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study)", JPEN J Parenter Enteral Nutr, 17, pp.407~413 (1993)
  54. Scolapio JS, "Treatment of short-bowel syndrome", Curr Opin Clin Nutr Metab Care, 4, pp.557~560 (2001)
  55. Coëffier M, "Potential for amino acids supplementation during inflammatory bowel diseases", Inflamm Bowel Dis, 16, pp.518~524 (2010)
  56. Lacey JM, "The effects of glutamine-supplemented parenteral nutrition in premature infants", JPEN J Parenter Enteral Nutr, 20, pp.74~80 (1996)
  57. Wang Y, "Protective effect of parenteral glutamine supplementation on hepatic function in very low birth weight infants", Clin Nutr, 29, pp.307~311 (2010)
  58. Cohen-Wolkowiez M, "Immunotherapy in neonatal sepsis: advances in treatment and prophylaxis", Curr Opin Pediatr, 21, pp.177~181 (2009)

관련 논문AI추천

이 간행물의 다른 논문 (17건)